Kontrol Technologies Corp N.KNR

Independent Testing

[LivingTheDream1]

Paul indicated there has been 2 independent studies that have concluded without a doubt that the BioCloud device is very effective in identifying covid. Of course there are naysayers identified on the internet, even so called reputable Individuals, who claim alot more tests are required to validate effectiveness of the device. That is why the share price struggles to move forward. Soon we will get validation. Upside will be huge if it proves as effective as Paul indicates. Looking forward to the results!

[canyousayiii]

I believe more testing is being done i.e. lowering detection limits. Although someone may not call this testing because that is not how that has been termed. Doesn't matter what anyone says. The article I read says that even spread of influenza is still being studied. Things can be studied for years and decades and forever. Business does not wait for all answers but for reasonable answers

[Qrewpt]

I agree with everything you're saying except your valuation is way too low. If we get visibility to sales of 1000 units per month, or 5% of initial manufacturing capacity at a 50% discount, knr is trading at 1x sales fully diluted. If the price that knr trades at today is accurate, I would say they expectations are extremely low with very low likelyhood being assigned by the market of

[canyousayiii]

You are correct. I always try to be ultra conservative. In my head doing the quick calcs, I missed a digit when dreaming about 10k units per month. North of $15 per share would be 1,000 units per month using a 5x multiple. This is a dream play if everything goes well.

[BeCool2]

Guys I'm not sure but 'lower detection limit' testing sounds like a CSA thing. That is, required to be quantified/measured (for a device like this one) and confirmed in order to "qualify" for CSA certification -- to confirm its 'specifications' in performance. It's reasonable in order to market a product which intends to make claims about "efficacy" or

[canyousayiii]

We should probably ask what this lower detection limit work entails. I dont think it is part of CSA thing. CSA will certify electrical safety and I think in terms of performance they will test that it does what it says. If the KNR limit is X, they will test for X. I dont think if they tested for X and it worked with X that the CSA will tell them that they have to make a better product with a lower

[Qrewpt]

Knr always said that defining the low detection limit is part of commercialization. That's understandable because if you are a buyer, you need this information to determine how many units you need, and which rooms they would be able to be used in, and the level of occupancy required in each room. Without this information, you wouldn't buy. As for hints, Paul's earlier interviews he

[BeCool2]

All I was responding to was the implication (I think was being made by some) that lower detection limits (LDL) was a 'testing' thing that represented some type of hurdle/requirement (and thus "unknown" to us/the market about product viability and therefore some type of RISK) -- which it most certainly is not. Probably not a CSA thing... The product had been 'validated'

[BeCool2]

So yeah, Qrewpt everything you said I agree with and sounds right (and thorough as heck in terms of detail from Paul and chronology). It's straightforward, so I get a bit annoyed by misinformation which can cast doubt on where things are at (and how good of a job management has done and continue to do) and possibly unduly negatively affect sentiment on the stock/BioCloud.

[canyousayiii]

From an investment perspective, the lower detection limit reference may have been a detail that is not required. More for the customers. He did always say that LDL is part of commercialization but that is confusing when suggesting that something will be done a bit differently than what was tested. Anyhow, just keep going, and hopefully they meet their November timeline. As for an acquisition

[Freddy6980]

In the last interview he said he see Kontrol being a Mid-Cap company which is between 2-10B. Fun stuff coming